SCHEMBL5147347

SCHEMBL5147347

CC1(C)NC(=O)N(CCNc2ncc(-c3cccc(O)c3)c(-c3cc(Cl)c(Cl)s3)n2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 3/20 0.38
RAF1 P04049 10/20 0.38
BRAF P15056 10/20 0.38
FGFR1 P11362 2/20 0.36
FLT3 P36888 2/20 0.36
ERN1 O75460 1/20 0.36
ABL1 P00519 1/20 0.36
MAPK8 P45983 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
NTRK2 Q16620 1/20 0.36
HIPK1 Q86Z02 1/20 0.36
MAP3K20 Q9NYL2 1/20 0.36
HTT P42858 1/20 0.35
EGFR P00533 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5149006 0.93 ADORA1 (0.39) ADORA1RAF1BRAFFGFR1FLT3
SCHEMBL5147476 0.88 HSD17B1 (0.39) ADORA1RAF1BRAFFGFR1FLT3
SCHEMBL5145850 0.88 HSD17B1 (0.38) ADORA1RAF1BRAFFGFR1FLT3
SCHEMBL2973501 0.87 ADORA1 (0.39) ADORA1RAF1BRAFFGFR1FLT3
SCHEMBL5149101 0.85 RAF1 (0.37) ADORA1RAF1BRAFFGFR1FLT3
SCHEMBL5147378 0.81 ADORA1 (0.40) ADORA1FGFR1ABL1MAPK14HTT
SCHEMBL5145972 0.81 RAF1 (0.39) RAF1BRAFFGFR1FLT3ERN1
SCHEMBL5147429 0.80 ADORA1 (0.37) ADORA1BRAFABL1HTTMEN1
SCHEMBL5148381 0.80 BRAF (0.39) RAF1BRAFFGFR1FLT3ERN1
SCHEMBL2984465 0.80 ADORA1 (0.39) ADORA1RAF1BRAFFGFR1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed